News
October 4, 2024
OnKure Announces Closing of Merger with Reneo Pharmaceuticals and Concurrent Private Placement of $65 Million
July 25, 2024
OnKure Announces the Appointment of Dylan Hartley, Ph.D. as Chief Scientific Officer
June 19, 2024
OnKure Announces the Appointment of Rogan Nunn, J.D., as General Counsel and Secretary
- View All News